Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma

Area of Science:

• Oncology
• Genetics
• Pathology

Background:

• BRCA1 and BRCA2 mutations are crucial in ovarian cancer development.
• Identifying genotype-specific morphologic features can improve diagnosis and treatment strategies.
• High-grade serous carcinomas (HGSCs) exhibit diverse histopathological patterns.

Purpose of the Study:

• To investigate the association between common morphologic features of ovarian carcinomas and BRCA1/BRCA2 deficiencies.
• To determine if specific histological patterns can predict BRCA1/BRCA2 mutation status in HGSCs.
• To develop algorithms for identifying BRCA1-deficient tumors based on morphology.

Main Methods:

• Retrospective analysis of 43 HGSCs from Memorial Sloan-Kettering Cancer Center.
• Histopathological assessment of tumor architecture, mitotic index, TILs, necrosis, and SET features.
• Comparison of morphologic features between BRCA1/BRCA2-associated and unassociated cases.
• Development and validation of predictive algorithms using tumor morphology characteristics.

Main Results:

• BRCA1-associated HGSCs showed significantly more SET features, higher mitotic indexes, increased TILs, and specific necrosis patterns compared to unassociated cases.
• BRCA2-associated cases also tended towards SET features but had fewer TILs and less necrosis.
• Algorithms incorporating SET features, necrosis, and mitotic index demonstrated high sensitivity and negative predictive value in identifying BRCA1-deficient tumors.

Conclusions:

• Specific morphologic features, particularly SET features, are strongly associated with BRCA1 deficiency in HGSCs.
• Morphological assessment can serve as a valuable tool for predicting BRCA1/BRCA2 genotype in ovarian cancer.
• These findings support the potential for integrating histopathology with genetic profiling for personalized ovarian cancer management.